LOX and liver cancer: In addition, TGF-β1 has been shown to cause a dose-dependent increase in the expression levels and activity of LOX family members in a range of cell lines, including cardiac fibroblasts, liver cancer cells and hepatocellular carcinoma cells [24,79,80,81,82,83,84].